Plant-Based Therapies for Circulatory Disorders
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: 22 August 2024 | Viewed by 247
Special Issue Editor
Interests: natural products; bioactive compounds; kidney disease; hypertension; cardiovascular disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Circulatory disorders are one of the principal reasons for morbidity and mortality worldwide. There are numerous distinct circulatory apparatus diseases that interfere with the complex system responsible for blood delivery around the body. Atherosclerosis, myocardial infarction, cardiac ischemia, heart failure, hypertension, and stroke are examples of diseases that can affect the circulatory system.
Lifestyle changes, including weight loss, a healthy diet, regular exercise, and not smoking, are essential for the treatment and prevention of all circulatory diseases. The choice of drug therapy will differ depending on the type of circulatory disease, according to its associated symptoms. However, despite all this knowledge, the therapeutic options available are not yet sufficient for the control of many patients and their pathologies. Therefore, there is a strong demand for innovative treatment possibilities, the most promising of which are those obtained from medicinal plants, which contain inestimable supplies of metabolites with substantial therapeutic capacity.
This Special Issue will summarize the advantages of the plant-based therapies that have been investigated for circulatory disorders and will introduce potential candidates for innovative therapeutic development.
Dr. Priscila De Souza
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- plant extracts
- isolated compounds from medicinal plants
- hypertension
- dyslipidemia
- atherosclerosis
- myocardial infarction
- cardiac ischemia
- heart failure
- stroke
- kidney disease
